Utah Lawmaker Proposes Changes To State Sex Education Law

In Utah on Wednesday, the Planned Parenthood Action Council hosted a meeting for state lawmakers and local residents to discuss proposed revisions to the state’s sex education law, the Salt Lake Tribune reports. During the meeting, state Rep.

FDA Warns of Increased Danger with HIV Drug

WASHINGTON (MedPage Today) — The FDA alerted healthcare professionals that the HIV medication etravirine (Intelence) may cause severe skin reactions, and the manufacturer has updated the drug’s label accordingly.

FDA Staff Pan Data on AML Drug

An application to expand the use of clofarabine (Clolar) to include acute myeloid leukemia patients 60 and older received a cool reception from FDA staff.

Global Markets Direct’s new report on Spinal Fusion Clinical Trial Analysis

Research and Markets has announced the addition of Global Markets Direct’s new report “Spinal Fusion Clinical Trial Analysis” to their offering.

Phase 2B clinical trial results of oral vernakalant to be presented at the ESC Congress 2009

Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Dr. Christian Torp-Pedersen is scheduled to present detailed findings from the Phase 2b clinical trial of vernakalant (oral) at the European Society of Cardiology (ESC) Congress 2009, being held in Barcelona, Spain from August 29 to September 2, 2009.

New report on product clinical trials conducted by Tissue Sealants manufacturers

Research and Markets has announced the addition of Global Markets Direct’s new report “Tissue Sealants Clinical Trial Analysis” to their offering.

Global Markets Direct’s new report pertains to product clinical trials being carried out by Repair and Restorative Materials manufacturers

Research and Markets has announced the addition of Global Markets Direct’s new report “Repair and Restorative Materials Clinical Trial Analysis” to their offering.

Two human biomarker assays that play a key role in the early detection of kidney damage provide assistance in drug development

Geneuity Clinical Research Services announces the recent validation and use in clinical trials of two human biomarker assays that play a key role in the early detection of kidney damage.

Court reverses the summary judgement decision on ANDA Patent litigation between Ortho McNeil and Caraco Pharmaceutical Laboratories

Caraco Pharmaceutical Laboratories, Ltd. announced today that a US Federal Circuit Court has reversed a portion of a previously decided summary judgment on ANDA Patent litigation between Ortho McNeil and Caraco regarding Ultracet(R).

Office of Orphan Products Development of the FDA grants Orphan Drug Designation to Quinazoline495

Families of Spinal Muscular Atrophy (Libertyville, IL) announced today that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted Orphan Drug Designation to Quinazoline495 for the treatment of Spinal Muscular Atrophy.